Prostatis Group’s Northrop Grumman NOC Stock Holding History
Bought
Maintained
Sold
Other funds holding NOC
Prostatis Group's NOC Position: Q2 2026 in Review
Prostatis Group increased its Northrop Grumman (NOC) stake by 58% in Q2 2026, buying an estimated $860K and bringing the position to 4,072 shares worth $2.07M. The position accounts for 0.48% of the portfolio, ranked #48.
Prostatis Group first reported a position in NOC in Q4 2019 and has held it in 27 quarters since. 1,811 funds tracked by Wall St. Rank hold NOC as of Q2 2026.
- Prostatis Group held 4,072 shares of Northrop Grumman worth $2.07M as of Q2 2026.
- Prostatis Group bought 1,491 Northrop Grumman shares in Q2 2026, an estimated $860K.
- Northrop Grumman made up 0.48% of Prostatis Group's portfolio in Q2 2026, its #48 holding.
- Prostatis Group first reported a position in Northrop Grumman in Q4 2019 and has held it in 27 quarters since.
- 1,811 funds tracked by Wall St. Rank held Northrop Grumman as of Q2 2026.
Based on Prostatis Group's 13F filing for Q2 2026, filed 14 Aug 2026.